Product Details
| Product Name:
JB002 |
CAS No.:
30408-07-2 |
| Purity:
99.74% |
Supply Ability:
10g |
| Release date:
2026/06/08 |
Product Introduction
Bioactivity
| Name | JB002 |
| Description | JB002, a myosin II inhibitor, exhibits potent activity with an IC50 of ≤10 μM. It holds potential for research applications in muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy. |
| In vitro | JB002 exhibits excellent selectivity between cardiac and skeletal muscle myosin, but shows no detectable activity against non-muscle IIB.[1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Corn Oil : 2 mg/mL (6.82 mM), Sonication is recommended.
DMSO : 28.1 mg/mL (95.8 mM), Sonication and heating to 60℃ are recommended.
|
| Keywords | Myosin | JB-002 | JB002 | JB 002 |
| Inhibitors Related | Mavacamten | (-)-Blebbistatin | Myosin V-IN-1 | JB062 | Aficamten | ATM-3507 | Myosin-IN-1 | 2,3-Butanedione 2-Monoxime | BPN 0026709 | 4-Hydroxyacetophenone | JB061 | Shz 1 |
| Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Cytoskeletal Signaling Pathway Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States